Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Adult patients with chronic liver disease respond poorly to HBV vaccines

Jan. 10, 2000

BLA submitted for PEG-Intron HCV therapy

Jan. 10, 2000

Another major market launch announced for infliximab

Jan. 10, 2000

Isis and Elan to develop antisense drug for HCV

Jan. 10, 2000

Centaur continues research into potential new treatments for IBD

Jan. 10, 2000

Centaur's new NRTs and their use for treating, preventing IBD

Jan. 3, 2000

Japanese labs discover new imidazoles useful for liver disease

Dec. 30, 1999

Byk Gulden compounds exhibit potent anti-H. pylori activity

Dec. 30, 1999

Agents for accelerating peristalsis in development at Dainippon

Dec. 29, 1999

Salix responds to FDA approvable letter and reacquires rights to UC treatment from AstraZeneca

Dec. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...